Trial Search Results
Online Automated Self-Hypnosis Program
After developing professional quality materials (audio) for an inexpensive automated self-hypnosis intervention program for treating smoking cessation, researchers aim to gain qualitative reviews of this program, and test its initial feasibility and effects on smoking cessation.
Stanford is currently accepting patients for this trial.
- Behavioral: Automated Self-Hypnosis
- 18 years or older
- Able to read and understand English
- Desire to quit smoking (specifically, report a motivation of ≥ 5 out of 10 to quit
smoking on a 10-point Likert-type scale)
- Having access to wireless internet connection or mobile data
- Reporting being a daily smoker for at least one year, smoking an average ≥ 5
cigarettes per day
- Meeting criteria for drug abuse of depressants, dissociative anesthetics,
hallucinogens, opioids, cocaine, or amphetamine within the last 3 months.
- Severe psychiatric or structural brain disease (i.e. psychosis, stroke with functional
impairment, dementia) or [current/recent risk to self. Indicated by denial of question
pertaining to inpatient hospitalization
- Hearing impairment that would impede ability to listen the auditory intervention
- Major illnesses impacting the study results
- Currently taking Wellbutrin, Chantix, or other pharmacological smoking cessation aids
that could confound results of the study
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study